Jeffrey Trigilio

Insider Reports History

Identity 1 fact
Location
Cambridge, MA
SEC filing record 1 fact
Filing signature
/s/ Maricel Montano, Attorney-in-Fact for Jeffrey Trigilio
SEC evidence 1 fact
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Jeffrey Trigilio:

Form 4 holding Chief Financial Officer

Cullinan Oncology, Inc.

Security class
Common Stock
Shares / value
133,919
Estimated value
$2,166,809
Report date
22 Feb 2024
Price
$16.18
Ownership
Direct
Form 4 holding Chief Financial Officer

XOMA Royalty Corp

Security class
Performance Stock Units
Shares / value
126,924
Estimated value
Report date
20 Apr 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

Cullinan Oncology, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
100,000
Estimated value
Report date
22 Feb 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Jeffrey Trigilio

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .